{"id":4097,"date":"2024-01-02T17:49:16","date_gmt":"2024-01-03T00:49:16","guid":{"rendered":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/"},"modified":"2024-01-02T17:49:16","modified_gmt":"2024-01-03T00:49:16","slug":"most-cancers-treatment-developer-cg-oncology-files-for-ipo","status":"publish","type":"post","link":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/","title":{"rendered":"Most cancers-treatment developer CG Oncology files for IPO"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"MW-BT-CO-20240102-706061\" role=\"document\">\n<p>Bladder-cancer treatment developer CG Oncology filed for an preliminary public offering with the Securities and Substitute Commission.<\/p>\n<p>The Irvine, Calif.-based biopharmaceutical firm is establishing a doable therapeutic for bladder-cancer patients who&#8217;re unresponsive to immunotherapy Bacillus Calmette-Guerin treatment.<\/p>\n<div>\n<p>CG Oncology did no longer reveal what number of shares it deliberate to give or give an estimated achieve fluctuate. The firm plans to make explain of proceeds primarily for supporting operations.<\/p>\n<p>The firm has utilized to list its shares on the Nasdaq Global Market below the ticker CGON.<\/p>\n<p>Morgan Stanley, Goldman Sachs &amp; Co., Cantor and Lifesci Capital are acting because the underwriters of the offering.<\/p>\n<\/p><\/div>\n<\/div>\n<p><a href=\"https:\/\/www.marketwatch.com\/story\/cancer-treatment-developer-cg-oncology-files-for-ipo-2a173f88?mod=mw_rss_topstories\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bladder-cancer treatment developer CG Oncology filed for an preliminary public offering with the Securities and Substitute Commission. The Irvine, Calif.-based biopharmaceutical firm is establishing a doable therapeutic for bladder-cancer patients who&#8217;re unresponsive to immunotherapy Bacillus Calmette-Guerin treatment. CG Oncology did no longer reveal what number of shares it deliberate to give or give an estimated<\/p>\n","protected":false},"author":1,"featured_media":4098,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Most cancers-treatment developer CG Oncology files for IPO - CBS26 Arizona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Most cancers-treatment developer CG Oncology files for IPO - CBS26 Arizona\" \/>\n<meta property=\"og:description\" content=\"Bladder-cancer treatment developer CG Oncology filed for an preliminary public offering with the Securities and Substitute Commission. The Irvine, Calif.-based biopharmaceutical firm is establishing a doable therapeutic for bladder-cancer patients who&#039;re unresponsive to immunotherapy Bacillus Calmette-Guerin treatment. CG Oncology did no longer reveal what number of shares it deliberate to give or give an estimated\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"CBS26 Arizona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CBSNews\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-03T00:49:16+00:00\" \/>\n<meta name=\"author\" content=\"cbs26.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@CBSNews\" \/>\n<meta name=\"twitter:site\" content=\"@CBSNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cbs26.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/\"},\"author\":{\"name\":\"cbs26.com\",\"@id\":\"https:\/\/cbs26.com\/#\/schema\/person\/6f199387dd167b788a14f8b99f8ff352\"},\"headline\":\"Most cancers-treatment developer CG Oncology files for IPO\",\"datePublished\":\"2024-01-03T00:49:16+00:00\",\"dateModified\":\"2024-01-03T00:49:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/\"},\"wordCount\":116,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cbs26.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png\",\"articleSection\":[\"Community\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/\",\"url\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/\",\"name\":\"Most cancers-treatment developer CG Oncology files for IPO - CBS26 Arizona\",\"isPartOf\":{\"@id\":\"https:\/\/cbs26.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png\",\"datePublished\":\"2024-01-03T00:49:16+00:00\",\"dateModified\":\"2024-01-03T00:49:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage\",\"url\":\"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png\",\"contentUrl\":\"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png\",\"width\":1280,\"height\":672,\"caption\":\"Most cancers-treatment developer CG Oncology files for IPO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cbs26.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Most cancers-treatment developer CG Oncology files for IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cbs26.com\/#website\",\"url\":\"https:\/\/cbs26.com\/\",\"name\":\"CBS26 Arizona\",\"description\":\"The Spirit of Arizona\",\"publisher\":{\"@id\":\"https:\/\/cbs26.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cbs26.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cbs26.com\/#organization\",\"name\":\"CBS26 Arizona\",\"url\":\"https:\/\/cbs26.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cbs26.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cbs26.com\/wp-content\/uploads\/2023\/12\/cbs26.fw_-1-e1703104627272.png\",\"contentUrl\":\"https:\/\/cbs26.com\/wp-content\/uploads\/2023\/12\/cbs26.fw_-1-e1703104627272.png\",\"width\":296,\"height\":96,\"caption\":\"CBS26 Arizona\"},\"image\":{\"@id\":\"https:\/\/cbs26.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CBSNews\/\",\"https:\/\/x.com\/CBSNews\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cbs26.com\/#\/schema\/person\/6f199387dd167b788a14f8b99f8ff352\",\"name\":\"cbs26.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cbs26.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e5c693e6a74bdbc1461a75db724fe465?s=96&d=mm&r=r\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e5c693e6a74bdbc1461a75db724fe465?s=96&d=mm&r=r\",\"caption\":\"cbs26.com\"},\"sameAs\":[\"http:\/\/cbs26.com\"],\"url\":\"https:\/\/cbs26.com\/index.php\/author\/cbs26-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Most cancers-treatment developer CG Oncology files for IPO - CBS26 Arizona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/","og_locale":"en_GB","og_type":"article","og_title":"Most cancers-treatment developer CG Oncology files for IPO - CBS26 Arizona","og_description":"Bladder-cancer treatment developer CG Oncology filed for an preliminary public offering with the Securities and Substitute Commission. The Irvine, Calif.-based biopharmaceutical firm is establishing a doable therapeutic for bladder-cancer patients who're unresponsive to immunotherapy Bacillus Calmette-Guerin treatment. CG Oncology did no longer reveal what number of shares it deliberate to give or give an estimated","og_url":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/","og_site_name":"CBS26 Arizona","article_publisher":"https:\/\/www.facebook.com\/CBSNews\/","article_published_time":"2024-01-03T00:49:16+00:00","author":"cbs26.com","twitter_card":"summary_large_image","twitter_creator":"@CBSNews","twitter_site":"@CBSNews","twitter_misc":{"Written by":"cbs26.com","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#article","isPartOf":{"@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/"},"author":{"name":"cbs26.com","@id":"https:\/\/cbs26.com\/#\/schema\/person\/6f199387dd167b788a14f8b99f8ff352"},"headline":"Most cancers-treatment developer CG Oncology files for IPO","datePublished":"2024-01-03T00:49:16+00:00","dateModified":"2024-01-03T00:49:16+00:00","mainEntityOfPage":{"@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/"},"wordCount":116,"commentCount":0,"publisher":{"@id":"https:\/\/cbs26.com\/#organization"},"image":{"@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png","articleSection":["Community"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/","url":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/","name":"Most cancers-treatment developer CG Oncology files for IPO - CBS26 Arizona","isPartOf":{"@id":"https:\/\/cbs26.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage"},"image":{"@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png","datePublished":"2024-01-03T00:49:16+00:00","dateModified":"2024-01-03T00:49:16+00:00","breadcrumb":{"@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#primaryimage","url":"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png","contentUrl":"https:\/\/cbs26.com\/wp-content\/uploads\/2024\/01\/4097-most-cancers-treatment-developer-cg-oncology-files-for-ipo.png","width":1280,"height":672,"caption":"Most cancers-treatment developer CG Oncology files for IPO"},{"@type":"BreadcrumbList","@id":"https:\/\/cbs26.com\/index.php\/2024\/01\/02\/most-cancers-treatment-developer-cg-oncology-files-for-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cbs26.com\/"},{"@type":"ListItem","position":2,"name":"Most cancers-treatment developer CG Oncology files for IPO"}]},{"@type":"WebSite","@id":"https:\/\/cbs26.com\/#website","url":"https:\/\/cbs26.com\/","name":"CBS26 Arizona","description":"The Spirit of Arizona","publisher":{"@id":"https:\/\/cbs26.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cbs26.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/cbs26.com\/#organization","name":"CBS26 Arizona","url":"https:\/\/cbs26.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cbs26.com\/#\/schema\/logo\/image\/","url":"https:\/\/cbs26.com\/wp-content\/uploads\/2023\/12\/cbs26.fw_-1-e1703104627272.png","contentUrl":"https:\/\/cbs26.com\/wp-content\/uploads\/2023\/12\/cbs26.fw_-1-e1703104627272.png","width":296,"height":96,"caption":"CBS26 Arizona"},"image":{"@id":"https:\/\/cbs26.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CBSNews\/","https:\/\/x.com\/CBSNews"]},{"@type":"Person","@id":"https:\/\/cbs26.com\/#\/schema\/person\/6f199387dd167b788a14f8b99f8ff352","name":"cbs26.com","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cbs26.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e5c693e6a74bdbc1461a75db724fe465?s=96&d=mm&r=r","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e5c693e6a74bdbc1461a75db724fe465?s=96&d=mm&r=r","caption":"cbs26.com"},"sameAs":["http:\/\/cbs26.com"],"url":"https:\/\/cbs26.com\/index.php\/author\/cbs26-com\/"}]}},"_links":{"self":[{"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/posts\/4097"}],"collection":[{"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/comments?post=4097"}],"version-history":[{"count":0,"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/posts\/4097\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/media\/4098"}],"wp:attachment":[{"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/media?parent=4097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/categories?post=4097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cbs26.com\/index.php\/wp-json\/wp\/v2\/tags?post=4097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}